Biohaven Pharmaceutical Holding Company Ltd. — Net Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0aa15eb1-dbf1-470f-9d87-e9628d855e9f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-846.6M | 2021-01-01 – 2021-12-31 | evidence 0001689813-22-000014 |
| FY 2020 | $-766.8M | 2020-01-01 – 2020-12-31 | evidence 0001689813-21-000024 |
| FY 2019 | $-528.8M | 2019-01-01 – 2019-12-31 | evidence 0001689813-21-000024 |
| FY 2018 | $-240.9M | 2018-01-01 – 2018-12-31 | evidence 0001689813-21-000024 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Biohaven Pharmaceutical Holding Company Ltd. — all facts · Revenue · Operating Income